From Medscape HIV/AIDS

Coverage from the

Conference on Retroviruses and Opportunistic Infections (CROI) 2021 Annual Meeting

March 06 - 10, 2021; Virtual

March 06 - 10, 2021 Virtual
  • CROI 2021 Vaginal pH May Predict CIN 2 Progression in HIV-Positive Women The researchers evaluated the role of human papillomavirus (HPV) type, local immune response, and markers of the cervicovaginal microbiome on the risk of CIN 2 persistence/progression.
  • CROI 2021 Lenacapavir Effective in Multidrug Resistant HIV Some observers expressed skepticism, noting that reduced viral load may have resulted not from lenacapavir but a simultaneous switch to an optimized backbone regimen.

Conference News

Popular News from CROI 2020

Medscape HIV/AIDS© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage